COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt

Introduction COVID-19 pandemic has affected the whole world, especially the frontline worriers. To get shielded through this war, the world is racing to reach and manufacture COVID-19 vaccines. Vaccination hesitancy is one of the significant obstacles to global health. Objectives This study aimed to assess the perception and attitude of healthcare workers in Egypt toward COVID-19 vaccines, acknowledge the determinants of their attitude, and the factors that could increase the acceptance of the vaccine. Methods an observational web-based anonymous survey was conducted on 385 Egyptian healthcare workers in different governorates. The questionnaire-based on Vaccine Hesitancy Survey Questions of the World Health Organization was available in Arabic and English languages and was tested for reliability. Results Regarding vaccination decision, 51% of the participants were undecided, 28% refused, and 21% accepted vaccination. Reasons for vaccine acceptance mainly were risks of COVID-19 (93%), safety (57.5%), and effectiveness (56.25%) of the vaccine. Simultaneously, the reasons for vaccine hesitancy were the absence of enough clinical trials (92.4%) and fear of side effects of the vaccine (91.4%). The leading factor that could increase vaccination acceptance among the participants was to get sufficient and accurate information about the available vaccines. The participants revealed a high mean level of concern for COVID-19 vaccines’ safety (3.8 of 5) that differs significantly among the different study groups ( P-value .002). Conclusion Despite the COVID-19 pandemic, only approximately 21% of Egyptian healthcare workers in our study accepted the COVID-19 vaccination. Vaccine hesitancy represents a major barrier to implementing vaccination programs.

Download Full-text

viewpoint TIME TO RESTART: PROTOCOL OF RESUMPTION OF ACTIVITIES OF A DERMATOLOGICAL CLINIC OF A LEVEL II HOSPITAL IN THE COVID-19 ERA. (Preprint)

10.2196/preprints.20732 ◽

2020 ◽

Author(s):

Federico Diotallevi ◽

Anna Campanati ◽

Giulia Radi ◽

Oriana Simonetti ◽

Emanuela Martina ◽

...

Keyword(s):

Healthcare Workers ◽

World Health ◽

New Wave ◽

Staff Members ◽

Level Ii ◽

The World ◽

Health Organization ◽

Spread Of Infection ◽

Hospital Wards ◽

Medical And Healthcare

UNSTRUCTURED Two months have passed since the World Health Organization (WHO) declared the pandemic of the Coronavirus Disease 19 (COVID-19), caused by the SARS CoV-2 virus, on March 11, 2020. Medical and healthcare workers have continued to be on the frontline to defeat this disease, however, continual changes are being made to their working habits which are proving to be difficult. Since the beginning of the pandemic, a major reorganisation of all hospital wards, including dermatological wards, has been carried out in order to make medical and nursing staff available in COVID wards and to prevent the spread of infection. These strategies, which were also adopted in our clinic, proved to be effective, as no staff members or patients were infected by the virus. Now, thanks to the global decrease in SARS-CovV2 infections, it is necessary to make dermatological wards accessible to patients again, but it is also essential to adopt specific protocols to avoid a new wave of infections.

Download Full-text

1.C. Workshop: How are digital solutions contributing to enhance immunization programmes and policies?

European Journal of Public Health ◽

10.1093/eurpub/ckaa165.005 ◽

2020 ◽

Vol 30 (Supplement_5) ◽

Author(s):

◽

Keyword(s):

Conceptual Framework ◽

World Health Organization ◽

Local Level ◽

Vaccine Uptake ◽

Childhood Vaccination ◽

World Health ◽

Vaccine Hesitancy ◽

The World ◽

Health Organization ◽

Immunization Programmes

Abstract As vaccine hesitancy and decreasing immunization coverage have been identified by the World Health Organization as global alarming health threats, it is of crucial importance to exploit the potential offered by digital solutions to enhance immunization programmes and ultimately increase vaccine uptake. We have previously developed and published a conceptual framework outlining how digitalization can support immunization at different levels: i) when adopted for health education and communication purposes, ii) in the context of immunization programmes delivery, and iii) in the context of immunization information systems management. The proposed workshop is co-organized by the EUPHA Digital health section (EUPHA-DH) and EUPHA Infectious diseases control section (EUPHA-IDC) and aims at discussing the current AVAILABILITY, USE and IMPACT of digital solutions to support immunization programmes at the international, national and local level, as well as, debating on how technical infrastructures on one side and normative and policy frameworks on the other side enable their implementation. We plan to have a rich set of contributions covering the following: the presentation of a conceptual framework identifying and mapping the digital solutions' features having the potential to bolster immunization programmes, namely: i) Personalization and precision; ii) Automation; iii) Prediction; iv) Data analytics (including big data and interoperability); and v) Interaction; the dissemination of key results and final outputs of a Europe-wide funded project on the use of Information & Communication Technology to enhance immunization, with particular reference to the use and comparative impact of email remainders and personal electronic health records, as well as the results of an international survey conducted to map and collect best practices on the use of different digital solutions within immunization programmes at the national and regional level; the firsthand experience of the United Kingdom NHS Digital Child Health Programme which developed, implemented and is currently evaluating a number of solutions to increase childhood vaccination uptake in England, including an information standard and information sharing services developed to ensure that the details of children's vaccinations can be shared between different health care settings the perspective and experience of the European Centre for Disease Prevention and Control (ECDC) for Europe and of the World Health Organization (WHO) for the global level of what has worked so far in the digitalization of immunization programmes around the world, what recommendations were developed and which barriers identified at the technical normative and policy level Key messages Digitalization has great potential to support immunization programmes but its practice and impact need to be measured. Country-level and international experiences have created qualitative and quantitative evidence on the effectiveness of digital intervention aimed at increasing vaccine uptake.

Download Full-text

From Syphilis to Autism, How the Anti-Vaccination Movement of Today is an Echo of the Past

McGill Journal of Medicine ◽

10.26443/mjm.v19i1.770 ◽

2021 ◽

Vol 19 (1) ◽

Author(s):

Kayleigh Beaveridge

Keyword(s):

Personal Narratives ◽

World Health ◽

Statistical Characteristics ◽

Vaccine Hesitancy ◽

Vaccine Preventable Diseases ◽

Vaccination Rates ◽

The World ◽

The One ◽

Health Organization ◽

The 19Th Century

Introduction: The anti-vaccination movement has led to decreased vaccination rates and increased vulnerability to vaccine-preventable diseases in the general population. In order to better understand the anti-vaccination movement of today, the anti-vaccination movement that emerged in the 19th century is examined and measured against the one observed in the 20th century. Discussion: Though the population of the 19th and 20th centuries differ in many regards and our knowledge of vaccine and immune mechanisms are far greater; the anti-vaccination movement seen today stands on the same pillars as that of the 1800s with the sentiment of fear at its core. Though the façade of these pillars has been altered to suit the world today, both movements exploited the influence of prominent public figures, maintained false associations with dire vaccine consequences and emphasized these through the use of visual media, repetition and personal narratives. The persistence of the anti-vaccination movement lies largely in the use of personal stories which are more impactful and memorable then the statistical characteristics of scientific study. Conclusion: The pro-vaccination movement must respond to the tactics used by the anti-vaccination movement and create accessible, understandable and equally impactful communication strategies in order to prevent the spread of misinformation and counter the efforts of the current anti-vaccination movement. Relevance: Vaccine hesitancy was listed amongst the top 10 global health threats in 2019 by the World Health Organization. In order to shift the negative rhetoric surrounding vaccines, the anti-vaccination movement of today and its historic roots need to be understood.

Download Full-text

Protecting healthcare workers from SARS-CoV-2 infection: practical indications

European Respiratory Review ◽

10.1183/16000617.0068-2020 ◽

2020 ◽

Vol 29 (155) ◽

pp. 200068 ◽

Cited By ~ 123

Author(s):

Martina Ferioli ◽

Cecilia Cisternino ◽

Valentina Leo ◽

Lara Pisani ◽

Paolo Palange ◽

...

Keyword(s):

High Risk ◽

Severe Acute Respiratory Syndrome ◽

World Health Organization ◽

Noninvasive Ventilation ◽

Healthcare Workers ◽

World Health ◽

Evidence Based ◽

The World ◽

Health Organization ◽

Respiratory Devices

The World Health Organization has recently defined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection a pandemic. The infection, that may cause a potentially very severe respiratory disease, now called coronavirus disease 2019 (COVID-19), has airborne transmission via droplets. The rate of transmission is quite high, higher than common influenza. Healthcare workers are at high risk of contracting the infection particularly when applying respiratory devices such as oxygen cannulas or noninvasive ventilation. The aim of this article is to provide evidence-based recommendations for the correct use of “respiratory devices” in the COVID-19 emergency and protect healthcare workers from contracting the SARS-CoV-2 infection.

Download Full-text

European Recommendations for the Management of Healthcare Workers Occupationally Exposed to Hepatitis

European Journal of Medicine and Natural Sciences ◽

10.26417/121khh78w ◽

2020 ◽

Vol 3 (2) ◽

pp. 67

Author(s):

Enis Uruci

Keyword(s):

Occupational Exposure ◽

Hepatitis B ◽

Healthcare Workers ◽

World Health ◽

Bloodborne Pathogens ◽

Mediterranean Countries ◽

Hbv Prevalence ◽

The World ◽

Health Organization

Exposure prevention is the primary strategy to reduce the risk of occupational bloodborne pathogen infections in healthcare workers (HCW). HCWs should be made aware of the medicolegal and clinical relevance of reporting an exposure, and have ready access to expert consultants to receive appropriate counselling, treatment and follow-up. Vaccination against hepatitis B virus (HBV), and demonstration of immunisation before employment are strongly recommended. HCWs with postvaccinal anti-HBs levels, 1-2 months after vaccine completion, -or=10 mIU/mL are considered as responders. Responders are protected against HBV infection: booster doses of vaccine or periodic antibody concentration testing are not recommended. Alternative strategies to overcome non-response should be adopted. Isolated anti-HBc positive HCWs should be tested for anti-HBcIgM and HBV-DNA: if negative, anti-HBs response to vaccination can distinguish between infection (anti-HBs -or=50 mIU/ml 30 days after 1st vaccination: anamnestic response) and false positive results(anti-HBs -or=10 mUI/ml 30 days after 3rd vaccination: primary response); true positive subjects have resistance to re-infection. and do not need vaccination The management of an occupational exposure to HBV differs according to the susceptibility of the exposed HCW and the serostatus of the source. When indicated, post-exposure prophylaxis with HBV vaccine, hepatitis B immunoglobulin or both must be started as soon as possible (within 1-7 days). In the absence of prophylaxis against hepatitis C virus (HCV) infection, follow-up management of HCV exposures depends on whether antiviral treatment during the acute phase is chosen. Test the HCW for HCV-Ab at baseline and after 6 months; up to 12 for HIV-HCV co-infected sources. If treatment is recommended, perform ALT (amino alanine transferase) activity at baseline and monthly for 4 months after exposure, and qualitative HCV-RNA when an increase is detected. Introduction Bloodborne pathogens such as hepatitis B (HBV) and C virus (HCV) represent an important hazard for healthcare workers (HCWs) [1]. In the general population, HCV prevalence varies geographically from about 0.5 percent in northern countries to 2 percent in Mediterranean countries, with some 5 million chronic carriers estimated in Europe; while HBV prevalence ranges from 0.3 percent to 3 percent. The World Health Organization (WHO) estimates that each year in Europe 304 000 HCWs are exposed to at least one percutaneous injury with a sharp object contaminated with HBV, 149 000 are exposed to HCV and 22 000 to HIV. The probability of acquiring a bloodborne infection following an occupational exposure has been estimated to be on average. Bloodborne pathogens such as hepatitis B (HBV) and C virus (HCV) represent an important hazard for healthcare workers (HCWs) [1]. In the general population, HCV prevalence varies geographically from about 0.5 percent in northern countries to 2 percent in Mediterranean countries, with some 5 million chronic carriers estimated in Europe; while HBV prevalence ranges from 0.3 percent to 3 percent. The World Health Organization (WHO) estimates that each year in Europe 304 000 HCWs are exposed to at least one percutaneous injury with a sharp object contaminated with HBV, 149 000 are exposed to HCV and 22 000 to HIV.We present here recommendations for the general management of occupational risk of bloodborne infections, HBV vaccination and management of HBV and HCV exposures. A description of the project and recommendations for HIV post-exposure management, including antiretroviral prophylaxis, has been previously published [2], and so issues related to occupational risk and prevention of HIV infection following an occupational exposure will not be discussed further.

Download Full-text

STUDI PENGARUH STATUS PERKAWINAN DAN PEKERJAAN PADA PASIEN TUBERKULOSIS DI RUMAH SAKIT DKT PURWOKERTO

Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan ◽

10.35960/vm.v10i2.438 ◽

2019 ◽

Vol 10 (2) ◽

pp. 46-51

Author(s):

Peppy Octaviani

Keyword(s):

Infectious Disease ◽

Developing Countries ◽

Pulmonary Tuberculosis ◽

Descriptive Study ◽

World Health ◽

P Value ◽

Cross Sectional ◽

Pulmonary Tb ◽

The World ◽

Health Organization

ABSTRACT Pulmonary tuberculosis (TB) is a contagious pulmonary infectious disease that is still a health problem in the world, especially developing countries. Tuberculosis has been proclaimed by WHO (World Health Organization) as Global Emergency since 1992. The purpose of this study is to find out what physical characteristics are at risk of tuberculosis in DKT Hospital Purwokerto. The research design used in this study was a descriptive study with a cross-sectional approach to determine the characteristics of pulmonary TB patients who were adherent to treatment and those who did not comply with treatment at the DKT Hospital in Purwokerto. This research was conducted at the DKT Purwokerto Hospital in May 2018. The samples studied in this study were pulmonary TB patients who were obedient to treatment and non-compliance with treatment at the DKT Purwokerto Hospital for the period of 1 January - 30 December 2017 that met the sample criteria. The results of the study have no relationship between age and the results of sputum examination at the Purwokerto DKT Hospital (p value = 0.286), there is no relationship between sex with the results of sputum examination at DKT Purwokerto Hospital (p value = 0.261). Keywords: Pulmonary TBC, Characteristics, Phlegm Examination

Download Full-text

Diagnostic challenges and pockets of susceptibility identified during a measles outbreak, Luxembourg, 2019

Eurosurveillance ◽

10.2807/1560-7917.es.2021.26.22.2000012 ◽

2021 ◽

Vol 26 (22) ◽

Author(s):

Michel Kohnen ◽

Patrick Hoffmann ◽

Caroline Frisch ◽

Emilie Charpentier ◽

Aurélie Sausy ◽

...

Keyword(s):

World Health Organization ◽

Healthcare Workers ◽

World Health ◽

Country Of Birth ◽

Winter Sports ◽

Measles Elimination ◽

Measles Outbreak ◽

The World ◽

Neighbouring Country ◽

Health Organization

Luxembourg was among the first countries in the World Health Organization (WHO) European Region documenting interruption of endemic measles transmission, but an increased incidence was registered in spring 2019. The outbreak started with an unvaccinated student who had been to a winter sports resort in a neighbouring country, where a measles outbreak was ongoing. Subsequently, 12 secondary and two tertiary cases were confirmed among students from the same school, relatives and healthcare workers, as well as six probably unrelated cases. Only 11 cases initially fulfilled the WHO definition for suspected measles cases. Fourteen of 20 cases with information on country of birth and the majority of unvaccinated cases (10/12) were born outside of Luxembourg. Measles IgM antibody results were available for 16 of the confirmed cases, and five of the eight IgM negative cases had been vaccinated at least once. All 21 cases were PCR positive, but for three previously vaccinated cases with multiple specimen types, at least one of these samples was negative. The outbreak highlighted diagnostic challenges from clinical and laboratory perspectives in a measles elimination setting and showed that people born abroad and commuters may represent important pockets of susceptible people in Luxembourg.

Download Full-text

Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines

Vaccines ◽

10.3390/vaccines9080914 ◽

2021 ◽

Vol 9 (8) ◽

pp. 914

Author(s):

Ahmed Yaqinuddin ◽

Areez Shafqat ◽

Junaid Kashir ◽

Khaled Alkattan

Keyword(s):

Monoclonal Antibody ◽

Protective Immunity ◽

Antibody Therapy ◽

Antiviral Drugs ◽

World Health ◽

Significant Morbidity ◽

Vaccination Programs ◽

The World ◽

Feasible Option ◽

Health Organization

SARS-CoV-2 causes severe acute respiratory syndrome, which has led to significant morbidity and mortality around the world. Since its emergence, extensive prophylactic and therapeutic countermeasures have been employed to successfully prevent the spread of COVID-19. Extensive work has been undertaken on using monoclonal antibody therapies, mass vaccination programs, and antiviral drugs to prevent and treat COVID-19. However, since antiviral drugs could take years to become widely available, immunotherapy and vaccines currently appear to be the most feasible option. In December 2020, the first vaccine against SARS-CoV-2 was approved by the World Health Organization (WHO) and, subsequently, many other vaccines were approved for use by different international regulators in different countries. Most monoclonal antibodies (mAbs) and vaccines target the SARS-CoV-2 surface spike (S) protein. Recently, mutant (or variant) SARS-CoV-2 strains with increased infectivity and virulence that evade protective host antibodies present either due to infection, antibody therapy, or vaccine administration have emerged. In this manuscript, we discuss the different monoclonal antibody and vaccine therapies available against COVID-19 and how the efficacy of these therapies is affected by the emergence of variants of SARS-CoV-2. We also discuss strategies that might help society cope with variants that could neutralize the effects of immunotherapy and escape the protective immunity conferred by vaccines.

Download Full-text

GAMBARAN PENGETAHUAN PASIEN TUBERCULOSIS PARU TENTANG PUTUS OAT (OBAT ANTI TUBERCULOSIS) DI RSU IPI MEDAN TAHUN 2019

Jurnal Ilmiah Keperawatan Imelda ◽

10.52943/jikeperawatan.v7i1.537 ◽

2021 ◽

Vol 7 (1) ◽

pp. 78-83

Author(s):

Jenti Sitorus

Keyword(s):

Pulmonary Tuberculosis ◽

Sampling Technique ◽

Medical Personnel ◽

World Health ◽

Primary Data ◽

Accurate Information ◽

Tuberculosis Patients ◽

The World ◽

Health Organization ◽

India And China

Pulmonary tuberculosis is an infectious disease that attacks the lungs which is typically characterized by the formation of granulomas causing tissue neocrosis. Pulmonary tuberculosis is caused by "mycrobacterium tuberculosis" a type of rod-shaped germ with a length of 1-4 / mm and a thickness of 0.3 -0.6 / mm. The World Health Organization (WHO) in 2007 stated that the number of tuberculosis sufferers in Indonesia was around 528 thousand or in third place in the world after India and China. The WHO report in 2009 recorded Indonesia's ranking according to fifth position with the number of tuberculosis sufferers of 429 thousand people, namely India, China, South Africa, Nigeria, and Indonesia (source WHO Global Tuberculosis Control 2010). This study aims to describe the knowledge of pulmonary tuberculosis patients about anti-tuberculosis drug withdrawal at RSU IPI Medan who is experiencing pulmonary tuberculosis. The sampling technique used in this research is Probability Sampling with the Random Sampling technique. Then the number of samples is 40 respondents. researchers used primary data. With the results of the study, it is hoped that respondents will increase their knowledge by finding out and caring about the health of others in order to prevent the transmission of pulmonary tuberculosis and change bad behavior for the better, with the participation and cooperation of medical personnel and other health teams in provide precise and accurate information.

Download Full-text

Antenatal care, care at birth, and breastfeeding during the Coronavirus (COVID-19) pandemic

Indian Journal of Community Health ◽

10.47203/ijch.2020.v32i01.005 ◽

2020 ◽

Vol 32 (1) ◽

pp. 15-18

Author(s):

Ranjitha Ranganathan ◽

Amir Maroof Khan ◽

Pragti Chhabra

Keyword(s):

Antenatal Care ◽

Healthcare Workers ◽

Scientific Information ◽

World Health ◽

Vulnerable Group ◽

Published Evidence ◽

Lactating Mothers ◽

The World ◽

Child Healthcare ◽

Health Organization

Coronavirus (COVID-19) pandemic has been declared by the World Health Organization after it has gripped many countries of the world. The exponential increase in the number of cases has resulted in panic and confusion among healthcare workers and the vulnerable population. Pregnant and lactating mothers are a vulnerable group and need evidence-based advice to protect the health of the mother and the child. Healthcare workers can play an important role in dispelling the myths and misconceptions among pregnant and lactating mothers regarding COVID-19, if they are equipped with scientific information on antenatal care, care at birth, and breastfeeding. This review attempts to summarize the published evidence related to antenatal care, care at birth and breastfeeding during the COVID-19 pandemic.

Download Full-text